A detailed history of Johnson Bixby & Associates, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Johnson Bixby & Associates, LLC holds 4,667 shares of MRK stock, worth $481,261. This represents 0.08% of its overall portfolio holdings.

Number of Shares
4,667
Previous 4,667 -0.0%
Holding current value
$481,261
Previous $577,000 8.32%
% of portfolio
0.08%
Previous 0.1%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $22,648 - $26,389
-200 Reduced 4.11%
4,667 $615,000
Q4 2023

Jan 18, 2024

SELL
$100.18 - $109.02 $10,018 - $10,902
-100 Reduced 2.01%
4,867 $530,000
Q3 2023

Oct 13, 2023

SELL
$102.95 - $114.33 $32,120 - $35,670
-312 Reduced 5.91%
4,967 $511,000
Q2 2023

Jul 21, 2023

BUY
$108.61 - $118.38 $3,041 - $3,314
28 Added 0.53%
5,279 $609,000
Q4 2022

Jan 18, 2023

SELL
$87.44 - $112.11 $8,219 - $10,538
-94 Reduced 1.76%
5,251 $0
Q3 2022

Oct 12, 2022

BUY
$84.53 - $94.96 $422 - $474
5 Added 0.09%
5,345 $460,000
Q2 2022

Jul 13, 2022

BUY
$83.49 - $94.64 $100,188 - $113,568
1,200 Added 28.99%
5,340 $487,000
Q4 2021

Jan 31, 2022

SELL
$72.28 - $90.54 $8,673 - $10,864
-120 Reduced 2.82%
4,140 $317,000
Q3 2021

Jun 16, 2022

SELL
$71.68 - $78.83 $437,534 - $481,178
-6,104 Reduced 58.9%
4,260 $320,000
Q3 2021

Oct 20, 2021

BUY
$71.68 - $78.83 $430,725 - $473,689
6,009 Added 137.98%
10,364 $778,000
Q2 2021

Aug 23, 2021

SELL
$70.31 - $77.77 $9,210 - $10,187
-131 Reduced 2.92%
4,355 $339,000
Q1 2021

May 25, 2021

SELL
$68.86 - $81.11 $5,784 - $6,813
-84 Reduced 1.84%
4,486 $346,000
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $327,988 - $364,000
4,570 New
4,570 $374,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Johnson Bixby & Associates, LLC Portfolio

Follow Johnson Bixby & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Bixby & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Johnson Bixby & Associates, LLC with notifications on news.